2003
PA Consulting Group identifies a novel method of authenticating pharmaceutical products to avoid counterfeits and ensure patient safety - Paper at Combating Pharmaceutical Fraud & Counterfeiting Conference
-
07 October 2003
Rob Whewell from PA Consulting Group, the leading international management, systems and technology consultancy, will provide insight into a novel method of authenticating pharmaceutical medicines at the point of dispensing, in a paper to be given at SMI’s Combating Pharmaceutical Fraud & Counterfeiting Conference at The Hatton, London UK on 7 October (3pm).
The WHO (World Health Organisation) estimates 10% of medicines worldwide are counterfeit. Often considered a problem of the developing world (where the proportion can be as high as 40%), recent cases of counterfeit medicines discovered in the US supply chain have shaken consumer confidence, with some post-consumption discoveries leading to law suits against distributors by affected patients.
Rob’s paper will:
- consider recent, salient cases of drug counterfeiting that have reached the market and heightened concern over patient safety
- explain current measures being taken by manufacturers to address the problem
- propose a radical new solution to this serious weakness in medicine supply that will ensure caveat emptor need no longer apply in the case of prescription pharmaceuticals, and that patient safety is protected.
It will be of particular interest to all marketing managers and anyone involved in product supply.
SMi Conferences – Combatting Pharmaceutical Fraud & Counterfeiting, 6 and October 2003, The Hatton, London, UK.
http://www.smi-online.co.uk/events/overview.asp?is=4&ref=1376
PA Consulting Group’s Life Sciences practice has expertise in strategic alliance management and partnering; commercial strategy; R&D performance improvement; manufacturing and operational excellence; and technology assessment, as well as in process and product development for pharmaceutical companies, medical device and biotechnology companies and business across the life science value chain. Its technology expertise allied to pharmaceutical industry insight enables it to deliver innovative solutions for business advantage.
For more information, please contact:
|
| John O'Neill |
| PA Consulting Group |
| Cambridge Technology Centre |
| Melbourn |
| Royston, HERTS |
| SG8 6DP |
| United Kingdom |
|
|
Tel: +44 1763 267 133 |
|
Fax: +44 1763 267135 |
|
E-mail:
john.o'neill@paconsulting.com |
|
|
|
Notes to editors
PA Consulting Group is a leading management, systems and technology consulting firm, with a unique combination of these capabilities. Established almost 60 years ago, and operating world-wide from over 40 offices in more than 20 countries, PA draws on the knowledge and experience of around 3,300 people, whose skills span the initial generation of ideas and insights all the way through to detailed implementation.
PA builds strategies for the creation and capture of shareholder and customer value, and helps clients accelerate business growth through innovation and the application of technology. PA works with clients to improve performance, mobilize human resources and deliver change effectively, including managing major projects, and designing and implementing enterprise-wide systems and full e-business solutions.
PA focuses on creating benefits for clients rather than merely proposing them, and this focus is supported by an outstanding implementation track record in every major industry and for governments around the world. PA also develops leading-edge technology both for its clients and within its own portfolio of venture companies in areas ranging from software to wireless technology to life sciences.
PA distinguishes itself from its competitors through the range and quality of its people, the depth of its industry insight, its development and use of technology, and also its independence and culture of respect, collaboration and flexibility in working with clients.
We are proud that our clients say 'PA makes it happen'.
|
